CLTR COULTER PHARMACEUTICAL | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
CLTR COULTER PHARMACEUTICAL

An SI Board Since January 1997

Posts	SubjectMarks	Bans	Symbol
666	17	0	CLTR

Emcee: HARRY GIBSON	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
41	Both Bexxar and Rituximab utilize antibodies that attach to the CD20 antigen th	Dr. John M. de Castro	-	9/5/1997
40	How does this compare with the drug Rituximab from Idec Pharmaceuticals (IDPH	HARRY GIBSON	-	9/5/1997
39	CLTR has begun outpatient treatment with Bexxar. biz.yahoo.com This is an imp	Dr. John M. de Castro	-	9/4/1997
38	Yeah, we need to get a proper definition of partial responses. I just assumed i	Andrew H	-	7/30/1997
37	Andrew, maybe some of the experts can help me here but not every patient that h	Vector1	-	7/29/1997
36	Rich, this is a summary of Table 2 of the NEJM 1993 paper. The title is "	Pseudo Biologist	-	7/29/1997
35	Max - If you could post the doses for red marrow, liver, spleen, kidneys and th	Richard Belanger	-	7/29/1997
34	>>So, retreatment has been tried pretty much along the lines you suggeste	Andrew H	-	7/29/1997
33	Andrew et al, I read the Kaminski articles (got them as part of CLTR's inf	Pseudo Biologist	-	7/29/1997
32	>>I have little to add except that I recall reading that of the partial r	Andrew H	-	7/29/1997
31	Max, Richard and Andrew, I am delighed you guys have lit up the CLTR thread. I	Vector1	-	7/28/1997
30	Steve, is the difference between 140K current and. 50-60K *new cases per year	aggressive investor	-	7/28/1997
29	Rich, thanks for reminding me of the press release. I am repasting part of it	Pseudo Biologist	-	7/28/1997
28	Have to agree in regard to the mortgage and holding your breath. Maybe I'	Andrew H	-	7/28/1997
27	PB - Coulter reported doses to "other" organs, such as kidneys, splee	Richard Belanger	-	7/28/1997
26	Sorry for misplacing the "why" I was referring on deciding if the tr	Pseudo Biologist	-	7/28/1997
25	Thanks, wasn't aware that the rad dose was so high. Is it long term radiati	Andrew H	-	7/28/1997
24	>>Andrew, actually this mystery is not quite as deep as it may seem. If,	Andrew H	-	7/28/1997
23	Andrew, actually this mystery is not quite as deep as it may seem. If, for exa	Pseudo Biologist	-	7/28/1997
22	>>On Bexxar, I think the key issue is to figure out why the partial respo	Andrew H	-	7/28/1997
21	Andy - On the issue of re-treatment, keep in mind that many of the healthy orga	Richard Belanger	-	7/28/1997
20	Howdy, I failed to find the labeling info for OKT3 in the allocated 5-10 minute	Pseudo Biologist	-	7/28/1997
19	PA (PseudoArgumentative!), >>I am trying to be more than conservative he	Andrew H	-	7/28/1997
18	Andrew, argumentative, moi?? I am trying to be more than conservative here and	Pseudo Biologist	-	7/28/1997
17	Hi PB, even more argumentative than usual. (:>) Don't want to give me an	Andrew H	-	7/28/1997

Go to reply# or date (mm/dd/yy):